Skip to content

Study · Animal study (in vivo) · rhesus monkey · 1997

1 result

Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development.

Jones AJ, Putney S, Johnson OL, Cleland JL

Advanced drug delivery reviews1 Oct 1997Cited by 78 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In juvenile rhesus monkeys, continuous rhGH produced a greater total IGF-I response than daily rhGH.

    In plain wordsIn juvenile rhesus monkeys, continuous rhGH produced a greater total IGF-I response than daily rhGH.

    Outcome
    IncreaseTotal IGF-I response
    Study

    rhesus monkeyn: not reported in source

    juvenile rhesus monkeys
    Comparator
    Daily rhGH administration
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Juvenile rhesus monkey studies revealed that continuous rhGH administration resulted in a greater total insulin-like growth factor-I (IGF-I) response than daily rhGH administration,

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:37 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.